This content is from: Portfolio Morning Brief: Elliott Identifies New Activist Target Health care company MEDNAX is now in the crosshairs of the multistrategy manager, which says the stock is undervalued. By Stephen Taub November 17, 2017
This content is from: Portfolio The E-mail Bill Ackman Wasn’t Supposed to See The activist hedge fund manager is disputing how ADP CEO Carlos Rodriguez characterized their interactions in an e-mail he sent to Ackman by mistake. By Michelle Celarier August 14, 2017
This content is from: Research The 2014 All-America Research Team: Chemicals, No. 3: P.J. Juvekar October 07, 2014
This content is from: Corner Office Viking’s Halvorsen Outlines Changes After Worst Year The Tiger Cub lays out to investors how he plans to boost future returns. By Stephen Taub January 23, 2017
This content is from: Premium Hedge Funds Really Like These Three Stocks An analysis of Goldman Sachs’ VIP list of stocks held by hedge funds shows that three companies keep popping up on the firm’s various screens. By Stephen Taub December 01, 2015
This content is from: Premium The SAC Pack of Cohen-Affiliated Funds Shows Mixed Results in Q3 How at least ten funds with ties to Steve Cohen’s SAC Capital Advisors stacked up in the first nine months of the year. By Stephen Taub November 09, 2016
